| # | Drug | Count |
|---|---|---|
| 0 | LEVETIRACETAM | 5 |
| 1 | BEVACIZUMAB | 3 |
| 2 | CISPLATIN | 3 |
| 3 | CLOBAZAM | 3 |
| 4 | GEMCITABINE | 3 |
| 5 | GEMCITABINE HYDROCHLORIDE | 3 |
| 6 | INTERFERON BETA-1A | 3 |
| 7 | LEVETIRACETAM IN SODIUM CHLORIDE | 3 |
| 8 | LEVETIRACETAM INJECTION | 3 |
| 9 | LEVETIRACETAM ORAL | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CHENODIOL | 1 | 0.0028 |
| 1 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 1 | 0.0004 |
| 2 | CLOBAZAM | 3 | 0.0002 |
| 3 | EPOPROSTENOL | 2 | 0.0002 |
| 4 | PHENYTOIN | 3 | 0.0001 |
| 5 | TOLVAPTAN | 1 | 0.0001 |
| 6 | EXTENDED PHENYTOIN SODIUM | 1 | 0.0001 |
| 7 | SILDENAFIL POWDER, | 2 | 0.0001 |
| 8 | GEMCITABINE HYDROCHLORIDE | 3 | 0.0001 |
| 9 | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL | 2 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Anti-epileptic Agent [EPC] | 3 |
| 1 | Benzodiazepine [EPC] | 3 |
| 2 | Integrin Receptor Antagonist [EPC] | 3 |
| 3 | Interferon beta [EPC] | 3 |
| 4 | Phosphodiesterase 5 Inhibitor [EPC] | 3 |
| 5 | Platinum-based Drug [EPC] | 3 |
| 6 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 3 |
| 7 | Corticosteroid [EPC] | 2 |
| 8 | Kinase Inhibitor [EPC] | 2 |
| 9 | Loop Diuretic [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vasopressin V2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 1 | Bile Acid [EPC] | 1 | 0.0000 |
| 2 | Integrin Receptor Antagonist [EPC] | 3 | 0.0000 |
| 3 | Sympathomimetic-like Agent [EPC] | 1 | 0.0000 |
| 4 | Phosphodiesterase 5 Inhibitor [EPC] | 3 | 0.0000 |
| 5 | Complement Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 3 | 0.0000 |
| 7 | Interferon beta [EPC] | 3 | 0.0000 |
| 8 | Prostacycline Vasodilator [EPC] | 2 | 0.0000 |
| 9 | Potassium Channel Blocker [EPC] | 1 | 0.0000 |